- Home
- Publications
- Publication Search
- Publication Details
Title
Current management of immune thrombocytopenia
Authors
Keywords
-
Journal
Hematology-American Society of Hematology Education Program
Volume 2013, Issue 1, Pages 276-282
Publisher
American Society of Hematology
Online
2013-12-06
DOI
10.1182/asheducation-2013.1.276
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk for Hospital Contact With Infection in Patients With Splenectomy
- (2013) Reimar W. Thomsen ANNALS OF INTERNAL MEDICINE
- No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura
- (2013) G. D'Arena et al. BLOOD
- Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
- (2013) S. Gudbrandsdottir et al. BLOOD
- Cellular immune dysfunction in immune thrombocytopenia (ITP)
- (2013) Christopher G. J. McKenzie et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
- (2013) David J. Kuter et al. BRITISH JOURNAL OF HAEMATOLOGY
- High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia
- (2013) David Gómez-Almaguer et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Pathophysiology and management of primary immune thrombocytopenia
- (2013) Hirokazu Kashiwagi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Individualized Treatment for Immune Thrombocytopenia: Predicting Bleeding Risk
- (2013) Cindy E. Neunert SEMINARS IN HEMATOLOGY
- Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care
- (2012) David J. Kuter et al. AMERICAN JOURNAL OF HEMATOLOGY
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
- (2012) D. M. Arnold et al. BLOOD
- Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
- (2012) V. L. Patel et al. BLOOD
- Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
- (2012) M. N. Saleh et al. BLOOD
- Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role ofMPLpolymorphisms
- (2012) Nicola Polverelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia
- (2012) Vishwanath K. Mahabir et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
- (2012) Matthieu Mahévas et al. JOURNAL OF CLINICAL INVESTIGATION
- Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
- (2012) Yi Liang et al. PLoS One
- A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia
- (2011) J. B. Bussel et al. BLOOD
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
- (2011) C. Neunert et al. BLOOD
- Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: Prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force
- (2011) John M. Davies et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP)
- (2011) Robert J. Klaassen et al. PEDIATRIC BLOOD & CANCER
- Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
- (2010) F. Zaja et al. BLOOD
- Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
- (2010) W. Bao et al. BLOOD
- Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
- (2010) Gregory Cheng et al. LANCET
- Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
- (2010) David J. Kuter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: A systematic review
- (2009) Joseph Mikhael et al. AMERICAN JOURNAL OF HEMATOLOGY
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Vascular complications after splenectomy for hematologic disorders
- (2009) S. E. Crary et al. BLOOD
- International consensus report on the investigation and management of primary immune thrombocytopenia
- (2009) D. Provan et al. BLOOD
- Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS)
- (2009) Rienk Tamminga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
- (2009) James B Bussel et al. LANCET
- Incidence of hepatitis B reactivation following Rituximab therapy
- (2008) Amr Hanbali et al. AMERICAN JOURNAL OF HEMATOLOGY
- Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- (2008) A. Podolanczuk et al. BLOOD
- Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
- (2008) R. Stasi et al. BLOOD
- Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura
- (2008) C. E. Neunert et al. BLOOD
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- The effect of anti-CD40 ligand in immune thrombocytopenic purpura
- (2008) Vivek L. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials
- (2008) James N. George et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
- (2008) David J Kuter et al. LANCET
- Boosting platelet production
- (2008) Andrew Wei et al. NATURE MEDICINE
- The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?
- (2008) Andrew R. Crow et al. TRANSFUSION MEDICINE REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now